Genetic testing for chemotherapy in non-small cell lung cancer

This publication has 16 references indexed in Scilit:

• Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial
  Annals of Oncology, 2002
• An Analysis of DNA Repair as a Determinant of Survival in Patients With Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 2002
• Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
  New England Journal of Medicine, 2002
• Loss of heterozygosity of nucleotide excision repair factors in sporadic ovarian, colon and lung carcinomas: implication for their roles of carcinogenesis in human solid tumors
  Cancer Letters, 2001
• ERCC1 and Thymidylate Synthase mRNA Levels Predict Survival for Colorectal Cancer Patients Receiving Combination Oxaliplatin and Fluorouracil Chemotherapy
  Journal of Clinical Oncology, 2001
• P53 plays a protective role against UV- and cisplatin-induced apoptosis in transcription-coupled repair proficient fibroblasts
  Oncogene, 2001
• Proneness to UV-induced apoptosis in human fibroblasts defective in transcription coupled repair is associated with the lack of Mdm2 transactivation
  Oncogene, 2000
• DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy
  International Journal of Cancer, 2000
• Persistent DNA damage induced by ultraviolet light inhibits p21waf1 and bax expression: implications for DNA repair, UV sensitivity and the induction of apoptosis
  Oncogene, 1998
• Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer
  New England Journal of Medicine, 1992